DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 62676 - 62700 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID ▼ Gene Name UniProt ID
C0152018 Esophageal carcinoma PARP2 10038 poly(ADP-ribose) polymerase 2 Q9UGN5
C0751690 Malignant Peripheral Nerve Sheath Tumor PARP2 10038 poly(ADP-ribose) polymerase 2 Q9UGN5
C0700095 Central neuroblastoma PARP2 10038 poly(ADP-ribose) polymerase 2 Q9UGN5
C0019158 Hepatitis PARP2 10038 poly(ADP-ribose) polymerase 2 Q9UGN5
C0011849 Diabetes Mellitus PARP2 10038 poly(ADP-ribose) polymerase 2 Q9UGN5
C0025517 Metabolic Diseases PARP2 10038 poly(ADP-ribose) polymerase 2 Q9UGN5
C0400966 Non-alcoholic Fatty Liver Disease PARP2 10038 poly(ADP-ribose) polymerase 2 Q9UGN5
C0010068 Coronary heart disease PARP2 10038 poly(ADP-ribose) polymerase 2 Q9UGN5
C0546837 Malignant neoplasm of esophagus PARP2 10038 poly(ADP-ribose) polymerase 2 Q9UGN5
C1332206 Adult Lymphoma PIGK 10026 phosphatidylinositol glycan anchor biosynthesis class K Q92643
C0024299 Lymphoma PIGK 10026 phosphatidylinositol glycan anchor biosynthesis class K Q92643
C2239176 Liver carcinoma PIGK 10026 phosphatidylinositol glycan anchor biosynthesis class K Q92643
C0009402 Colorectal Carcinoma PIGK 10026 phosphatidylinositol glycan anchor biosynthesis class K Q92643
C0027651 Neoplasms PIGK 10026 phosphatidylinositol glycan anchor biosynthesis class K Q92643
C1853926 NONAKA MYOPATHY GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0036572 Seizures GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C1096902 Infantile Sialic Acid Storage Disease GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0751336 Distal Muscular Dystrophies GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0026848 Myopathy GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0027651 Neoplasms GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0276289 Zika Virus Infection GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0342853 Sialuria GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C1096903 Sialic Acid Storage Disease, Finnish Type (disorder) GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0015469 Facial paralysis GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223
C0346647 Malignant neoplasm of pancreas GNE 10020 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase Q9Y223

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024